IH
iHuman Inc.
NYSE · Consumer Defensive · Education & Training Services · CN
$1.25
+3.31%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 779.1M | 807.0M | 922.2M | 1.0B | 985.5M |
| Cost of Revenue | 253.3M | 259.4M | 282.0M | 296.9M | 294.3M |
| Gross Profit | 525.8M | 547.6M | 640.2M | 721.3M | 691.2M |
| Operating Expenses | |||||
| R&D Expense | 209.2M | 208.4M | 247.8M | 257.5M | 313.5M |
| SG&A Expense | 281.2M | 272.4M | 320.5M | 303.8M | 266.1M |
| General & Admin Expense | 91.3M | 91.4M | 99.3M | 104.3M | 109.2M |
| Selling & Marketing Expense | 189.9M | 181.0M | 221.2M | 199.5M | 156.9M |
| Other Expenses | 341.7K | — | — | — | — |
| Total Operating Expenses | 490.7M | 480.9M | 568.2M | 561.4M | 579.6M |
| Cost and Expenses | 744.0M | 740.3M | 850.3M | 858.3M | 873.9M |
| Operating Income (EBIT) | 35.1M | 66.8M | 71.9M | 159.9M | 111.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | 28.5M | 12.2M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | 28.5M | 12.2M |
| Other Non-Op Income/Expense | 41.6M | 35.0M | 38.7M | 42.7M | 21.2M |
| Non-Operating Income (excl Interest) | (27.0M) | (35.0M) | (38.7M) | (42.7M) | (21.2M) |
| EBT (Pre-Tax Income) | 76.7M | 101.8M | 110.6M | 202.6M | 132.8M |
| Income Tax Expense | 3.3M | 6.4M | 12.0M | 21.7M | 23.0M |
| Bottom Line | |||||
| Net Income | 73.4M | 95.4M | 98.6M | 180.9M | 109.8M |
| Earnings from Cont. Ops | 73.4M | 95.4M | 98.6M | 180.9M | 109.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 73.4M | 95.4M | 98.6M | 180.9M | 109.8M |
| Per Share | |||||
| Basic EPS | $7.14 | $9.10 | $9.40 | $17.15 | $10.30 |
| Diluted EPS | $6.87 | $8.75 | $9.00 | $16.50 | $10.15 |
| Revenue Per Share | $76.22 | $78.51 | $88.00 | $96.39 | $92.44 |
| Shares | |||||
| Basic Shares Outstanding | 10.2M | 10.3M | 10.5M | 10.6M | 10.7M |
| Diluted Shares Outstanding | 10.6M | 10.7M | 10.8M | 11.0M | 10.8M |
| Profitability Metrics | |||||
| EBITDA | 64.0M | 109.5M | 124.3M | 214.3M | 143.6M |
| D&A | 1.9M | 7.7M | 13.7M | 11.7M | 10.8M |
| EBIT | 62.1M | 101.8M | 110.6M | 202.6M | 132.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026